Associate Professor
Fred Hutch Cancer Center
Dr. Josh Hill is an Associate Professor at the Fred Hutchinson Cancer Center and the University of Washington (UW) in the Vaccine and Infectious Disease Division. His NIH-funded research program is focused on studies to improve preventive and treatment strategies for viral and other infections in immunocompromised patients.
Disclosure(s): AlloVir: Advisor/Consultant, Grant/Research Support; Century Therapeutics: Advisor/Consultant; CSL Behring: Advisor/Consultant; ExeVir Bio: Advisor/Consultant; GeoVax: Advisor/Consultant, Grant/Research Support; Gilead Australia: Honoraria; Grifols: Advisor/Consultant; Karius: Advisor/Consultant, Travel; Medscape: Advisor/Consultant; Merck: Grant/Research Support; Moderna, Inc.: Board Member; Modulus: Advisor/Consultant; Oxford immunotec: Grant/Research Support; Sanofi Pasteur Inc.: Advisor/Consultant; Senti BioSciences, Inc: Advisor/Consultant; SymBio: Advisor/Consultant; Takeda: Grant/Research Support; Takeda Netherlands: Honoraria; UpToDate: Royalties
Monday, October 20, 2025
4:03 PM - 4:15 PM US ET
210 - T-Cell Modifying Therapies: What the ID Provider Needs to Know
Wednesday, October 22, 2025
10:30 AM - 11:45 AM US ET